Clinical prognostic factors predicting survival of motor neuron disease patients with gastrostomy: A retrospective analysis

Jie Yang,Yun Zhao,Mario Soares,Merrilee Needham,Andrea Begley,Emily Calton

DOI: https://doi.org/10.1002/mus.28064

2024-02-16

Muscle & Nerve

Abstract:Enteral feeding via gastrostomy is a key intervention to minimize weight loss in Motor Neuron Disease (MND). This retrospective study analyzed 94 MND patients who underwent gastrostomy in Australia. Body mass index (BMI) <18.5 kg/m2 at the time of gastrostomy insertion, older age, and greater weight loss from diagnosis to gastrostomy were associated with shorter survival time. Limb onset, non‐invasive ventilation (NIV) not being required, and daily NIV use that was tolerated when required were associated with longer survival. Introduction/Aims Enteral feeding via gastrostomy is a key intervention to prevent significant weight loss in Motor Neuron Disease (MND). The aim of this study was to explore demographic, clinical, and nutritional factors associated with survival time in MND patients with gastrostomy. Methods The retrospective study analyzed 94 MND patients (n = 58 bulbar‐onset and n = 36 limb‐onset) who underwent gastrostomy between 2015 and 2021. The primary outcome was the survival time from gastrostomy insertion to death. Independent variables of interest explored were: age at gastrostomy insertion, disease onset type, known genetic cause, use of riluzole, non‐invasive ventilation (NIV) use, forced vital capacity prior to gastrostomy, weight loss from diagnosis to gastrostomy insertion, and body mass index (BMI) at the time of gastrostomy insertion. Results The median survival time from gastrostomy to death was 357 days (± 29.3, 95%CI: 299.5, 414.5). Kaplan–Meier method and log‐rank test revealed patients with lower body mass index <18.5 kg/m2 at the time of gastrostomy insertion (p = .023) had shorter survival. Cox proportional hazards model with multivariable adjustment revealed that older age (p = .008), and greater weight loss from diagnosis to gastrostomy (p = .003) were associated with shorter survival time post gastrostomy. Limb onset (p = .023), NIV use not being required (p = .008) and daily NIV use when required and tolerated (p = .033) were associated with longer survival. Discussion Preventing or minimizing weight loss from MND diagnosis and encouraging NIV use when clinically indicated are modifiable factors that may prolong the survival of MND patients with gastrostomy.

neurosciences,clinical neurology